Literature DB >> 19603202

Factor analysis of microbiological activity data and structural parameters of antibacterial quinolones.

Marcin Koba1, Tomasz Baczek, Katarzyna Macur, Leszek Bober, Teresa Frackowiak, Adam Buciński, Danuta Rystok-Grabska, Jolanta Stasiak, Katarzyna Koba.   

Abstract

Factor analysis (FA) was performed on quinolone derivatives with antibacterial activity to model relationships between molecular descriptors and microbiological activities determined on five bacterial cell lines (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus pneumoniae). Molecular modeling studies were performed with the use of HyperChem software and MM+ molecular mechanics with the semi-empirical AM1 method. Factor analysis led to the extraction of two main factors, with the share of factor 1 amounting to about 76% and factor 2 to about 24% for all the parameters used in the statistical analysis. Moreover, FA results indicated that energy of orbitals lowest unoccupied molecular orbital, energy of ionization, electron affinity, electronegativity, maximum electron density, refraction and polarizability appeared to be descriptors important for the antibacterial activity of quinolones.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603202     DOI: 10.1007/s00894-009-0549-3

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  14 in total

Review 1.  The chemistry and biological profile of trovafloxacin.

Authors:  K E Brighty; T D Gootz
Journal:  J Antimicrob Chemother       Date:  1997-06       Impact factor: 5.790

Review 2.  Mechanism of action of and resistance to quinolones.

Authors:  D T Bearden; L H Danziger
Journal:  Pharmacotherapy       Date:  2001-10       Impact factor: 4.705

3.  The in vitro activity of BMS-284756, a new des-fluorinated quinolone.

Authors:  T M A Weller; J M Andrews; G Jevons; R Wise
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

4.  Comparative in vitro activity of gemifloxacin.

Authors:  A King; J May; G French; I Phillips
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

Review 5.  Quinolone generations: natural history or natural selection?

Authors:  P Ball
Journal:  J Antimicrob Chemother       Date:  2000-07       Impact factor: 5.790

6.  Chromatographic data for pharmacological classification of imidazol(in)e drugs.

Authors:  R Gami-Yilinkou; R Kaliszan
Journal:  J Chromatogr       Date:  1991-07-26

7.  Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus.

Authors:  L J Piddock; Y F Jin; D J Griggs
Journal:  J Antimicrob Chemother       Date:  2001-03       Impact factor: 5.790

8.  New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.

Authors:  J M Domagala; L D Hanna; C L Heifetz; M P Hutt; T F Mich; J P Sanchez; M Solomon
Journal:  J Med Chem       Date:  1986-03       Impact factor: 7.446

9.  In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.

Authors:  J A Hoogkamp-Korstanje
Journal:  J Antimicrob Chemother       Date:  1997-09       Impact factor: 5.790

10.  In vitro and in vivo antibacterial activities of DW286, a new fluoronaphthyridone antibiotic.

Authors:  Hee-Jeong Yun; Yu-Hong Min; Jung-A Lim; Jin-Wook Kang; So-Young Kim; Mi-Jeong Kim; Jae-Hee Jeong; Yun-Jeong Choi; Hyun-Jin Kwon; Yong-Ho Jung; Mi-Ja Shim; Eung-Chil Choi
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more
  1 in total

Review 1.  Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection.

Authors:  Cui Jun; Bian Fang
Journal:  BMC Cardiovasc Disord       Date:  2021-09-28       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.